Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 5, 2016

Primary Completion Date

January 13, 2021

Study Completion Date

June 25, 2021

Conditions
Diffuse Large B-Cell LymphomaB-cell Non-Hodgkin's Lymphoma
Interventions
DRUG

Debio 1562

Administered as IV Infusion.

DRUG

Rituximab

Administered as IV Infusion.

Trial Locations (39)

1756

Specialized Hospital for Active Treatment of Hematological Diseases,Clinic of Hematology, Sofia

2610

St. Augustinus Hospital, Department of Hematology, Wilrijk

3000

University Hospitals Leuven, Campus Gasthuisberg, Leuven

Multiprofile Hospital for Active Treatment - Hristo Botev, Vratsa, Vratsa

4002

"University Multiprofile Hospital for Active Treatment Sveti Georgi", Plovdiv

4032

University of Debrecen Clinical Center, Debrecen

5530

CHU UCL Namur asbl - Site Godinne, Yvoir

6500

Regional Hospital of Bellinzona and Valli, Oncology Institute of Southern Switzerland, Bellinzona

8900

Jan Yperman Ziekenhuis, Ieper

18009

Cherkasy Regional Oncology Center, Regional Treatment and Diagnostic Hematology Center, Cherkasy

19104

Abramson Cancer Center of The University of Pennsylvania, Philadelphia

21029

Podillia Regional Oncology Center, Vinnytsia

25123

Civil Hospital of Brescia, Brescia

27103

Novant Health Oncology, Winston-Salem

29303

Spartanburg Regional Healthcare System, Spartanburg

35211

Alabama Oncology, Birmingham

36100

Local Healthcare Company 8 Berica (Azienda ULSS8 Berica), Hospital San Bortolo of Vicenza, Vicenza

44195

Cleveland Clinic, Cleveland

55407

Abbott Northwestern Hospital, Virginia Piper Cancer Institute, Minneapolis

60126

University Hospital - Ospedali Riuniti Umberto I - GM Lancisi - G Salesi of Ancona, Ancona

61024

Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine, Kharkiv

61070

"Communal Non-profit enterprise Regional Center of Oncology", Kharkiv

61801

Carle Foundation Hospital, Cancer Center, Urbana

75246

Baylor University Medical Center, Dallas

90146

United Hospitals Villa Sofia Cervello, Palermo

98104

Swedish Medical Center, Seattle

625 00

University Hospital Brno, Brno

500 05

University Hospital Hradec Kralove, Hradec Králové

100 34

University Hospital Kralovske Vinohrady, Prague

128 08

General University Hospital in Prague, Prague

H-1122

National Institute of Oncology, Budapest

H-7624

Medical Center of the University of Pecs, Pécs

80-214

University Clinical Center in Gdansk, Gdansk

81-519

Provincial Hospitals in Gdynia Sp. z o.o. (LLC), Gdynia

30-510

Małopolskie Medical Centre, Krakow

20-090

St. John of Dukla Oncology Center of Lublin Land, Lublin

03022

National Institute of Cancer, Kyiv

03115

National Research Center for Radiation Medicine, Kyiv

04112

Kyiv City Clinical Hospital #9, City Hematology Center, Kyiv

Sponsors
All Listed Sponsors
lead

Debiopharm International SA

INDUSTRY